title: Induction of GVHD-like skin disease by passively transferred CD8(+) T-cell receptor transgenic T cells into keratin 14-ovalbumin transgenic mice.
abstract: To understand the mechanisms involved in immunological tolerance to skin-associated antigens, we have developed transgenic (Tg) mice that express a model self-antigen, membrane-bound chicken ovalbumin (OVA), under the control of a keratin 14 (K14) promoter. K14-mOVA Tg mice express OVA mRNA in the epidermis, and appear normal. K14-mOVA Tg mice failed to mount T cell and delayed type hypersensitivity reactions to OVA, suggesting that the Tg mice were tolerant to OVA. Skin dendritic cells, including Langerhans cells, may contribute to the tolerance induction because migratory skin DC derived from K14-mOVA efficiently activated CD8(+) T cells from OVA-specific T-cell receptor (Va2/Vb5) Tg (OT-I) mice. OT-I cells expanded and accumulated in skin-draining lymph nodes after intravenous injected into K14-mOVA mice and exhibited activation markers. Graft-versus-host disease-like skin lesions appeared in K14-mOVA mice by day 7 after injection of OT-I cells. These studies demonstrate that K14-mOVA Tg mice are susceptible to an autoimmunelike skin disease induced by passively transferred naïve CD8(+) OVA T-cell receptor Tg T cells, and serve as a good model for understanding self-tolerance and for the investigation of the pathogenesis, treatment and potential prevention of cell-mediated autoimmune reactions in skin.
authors.affiliation: Dermatology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
authors.forename: Akihiko
authors.initials: A
authors.lastname: Shibaki
authors.forename: Atsushi
authors.initials: A
authors.lastname: Sato
authors.forename: Jonathan C
authors.initials: JC
authors.lastname: Vogel
authors.forename: Fumi
authors.initials: F
authors.lastname: Miyagawa
authors.forename: Stephen I
authors.initials: SI
authors.lastname: Katz
mesh_terms: D019264:Adoptive Transfer; D000818:Animals; D001324:Autoantigens / Q000235:genetics / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D002465:Cell Movement / Q000276:immunology; D015870:Gene Expression / Q000276:immunology; D006086:Graft vs Host Disease / Q000276:immunology* / Q000503:physiopathology; D006968:Hypersensitivity, Delayed / Q000276:immunology / Q000503:physiopathology; D053547:Keratin-14; D007633:Keratins / Q000235:genetics*; D051379:Mice; D008822:Mice, Transgenic; D010047:Ovalbumin / Q000235:genetics* / Q000276:immunology; D011401:Promoter Regions, Genetic; D012871:Skin Diseases / Q000276:immunology* / Q000503:physiopathology; D019076:Transgenes
chemical_list: D001324:Autoantigens; D053547:Keratin-14; C507446:Krt14 protein, mouse; D007633:Keratins; D010047:Ovalbumin